MARKET

FEMY

FEMY

FEMASYS INC
NASDAQ
1.573
+0.103
+6.99%
Opening 12:30 03/28 EDT
OPEN
1.440
PREV CLOSE
1.470
HIGH
1.650
LOW
1.440
VOLUME
309.18K
TURNOVER
0
52 WEEK HIGH
4.750
52 WEEK LOW
0.2479
MARKET CAP
34.05M
P/E (TTM)
-1.6073
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at FEMY last week (0318-0322)?
Weekly Report · 3d ago
Analysts Offer Insights on Healthcare Companies: Femasys (FEMY) and NextCure (NXTC)
TipRanks · 03/21 18:30
Femasys Price Target Maintained With a $12.00/Share by Chardan Capital
Dow Jones · 03/21 17:04
Chardan Capital Reiterates Buy on Femasys, Maintains $12 Price Target
Benzinga · 03/21 16:54
Femasys Is Maintained at Buy by JonesTrading
Dow Jones · 03/21 12:28
Femasys Price Target Raised to $10.00/Share From $7.00 by JonesTrading
Dow Jones · 03/21 12:28
Analysts Are Bullish on Top Healthcare Stocks: Femasys (FEMY), BioNTech SE (BNTX)
TipRanks · 03/21 10:31
JAGX and GNPX among Health Care movers
On the Move JAGX and GNPX among Health Care movers. S&P 500 Health Care Sector -0.52% to 1692.4. Pharmaceuticals, Biotechnology & Life Science contributes 58% to index is down 0.67%. SCWorx Corp, XTLB, WORX, TFFP, TSHA, FEMY among health care sector gainers.
Seeking Alpha · 03/20 14:13
More
About FEMY
Femasys Inc. is a biomedical company. The Company is focused on providing women worldwide with non-surgical product technologies, accessible in the office, improving patient care and overall health economics. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. The Company also developed a technology platform, namely FemEMB for tissue sampling intended to be marketed alongside its other women-specific medical products in the physician’s office setting.

Webull offers Femasys Inc stock information, including NASDAQ: FEMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FEMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FEMY stock methods without spending real money on the virtual paper trading platform.